LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Appoints Erica Raether as Vice President of People, Culture and ESG
20 juil. 2021 07h00 HE | Recro Pharma, Inc.
EXTON, Pa., July 20, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
22157.jpg
Pharmaceutical Contract Manufacturing Industry M&A Implications and Outlook Report 2021: Objectives, M&A Activity 2018-2020, Target Characteristics, Acquirer Characteristics, Geography, Top Acquirers
16 juil. 2021 07h48 HE | Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition" report has been...
22157.jpg
Global Pharmaceutical Contract Manufacturing Market Report 2021: Market to Reach $130.2 Billion by 2026 - API/Bulk Drugs Segments is Projected to Account for $81.5 Billion
15 juil. 2021 07h23 HE | Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Enters Development and Manufacturing Agreement With New Client
13 juil. 2021 07h00 HE | Recro Pharma, Inc.
GAINESVILLE, Ga., July 13, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation...
logo 02.jpg
Pharmaceutical Contract Manufacturing Market Worth USD 174.2 Billion by 2026 at 6.0% CAGR - Report by Market Research Future (MRFR)
09 juil. 2021 12h00 HE | Market Research Future
New York, US, July 09, 2021 (GLOBE NEWSWIRE) -- Pharmaceutical Contract Manufacturing Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Pharmaceutical...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Reports Inducement Grants for New Staff
07 juil. 2021 07h00 HE | Recro Pharma, Inc.
EXTON, Pa., July 07, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of Directors
01 juil. 2021 08h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., July 01, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments
29 juin 2021 16h05 HE | Avid Bioservices, Inc
-- Recorded Fourth Quarter Revenue of $27.6 Million and Annual Revenue of $95.9 Million -- -- Achieved Four Consecutive Quarters of Operational Profitability During Fiscal 2021 -- -- Signed...
ElectronicCoating Logo 2020 - RGB.jpg
Electronic Coating Technologies Unveils New Brand Identity & Website
25 juin 2021 13h00 HE | Electronic Coating Technologies
ONTARIO, June 25, 2021 (GLOBE NEWSWIRE) -- Electronic Coating Technologies (ECT), leading provider of protective materials and application services for the electronics industry, reveals its new look...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices to Report Financial Results For Quarter and Fiscal Year Ended April 30, 2021 After Market Close on June 29, 2021
22 juin 2021 16h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...